Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Rheumatology

CME

DMARDS: Combination Therapy for the Treatment of Rheumatoid Arthritis

This month, Peter Barland, M.D. discusses
CME credit is no longer available for this conference.

Course Authors

Peter Barland, M.D.

Dr. Barland reports no commercial conflict of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Describe the rationale for using more than one DMARD in patients with rheumatoid arthritis

  • Recognize that subset of patients with rheumatoid arthritis who are likely to have progressive disease

  • Discuss the results of three DMARD treatment protocols for early rheumatoid arthritis.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

Treatment of Idiopathic Inflammatory Myopathy

With few FDA-approved medications available, the treatment of myositis is challenging.
Authors: Siamak Moghadam-Kia, M.D., Rohit Aggarwal, M.D. and Chester V. Oddis, M.D.
Estimated Time: 1 Hour
View Course
More

Idiopathic Inflammatory Myopathies: A 2016 Update

Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of autoimmune diseases, primarily affecting the skeletal muscles, which cause predominant proximal muscle weakness.
Authors: Julie J. Paik, M.D.. M.H.S. and Lisa Christopher-Stine, M.D., M.P.H.
Estimated Time: 1 Hour
View Course
More

The Current Treatment of Lupus Nephritis

Despite therapeutic advances, lupus nephritis continues to lead to significant morbidity and mortality with 10-15% of patients progressing to end-stage renal disease requiring renal replacement therapy.
Authors: Saakshi Khattri, M.D., and Peter Barland, M.D
Estimated Time: 1 Hour
View Course
More

Palindromic Rheumatism

An episodic recurring arthritis with unknown etiopathogenesis.
Authors: Sahitya Mallipeddi, M.D., Raghu Maddela, M.D., and Peter Barland, M.D.
Estimated Time: 1 Hour
View Course
More

Immunoglobulin G4-related Sclerosing Syndrome

This month, Peguy Saad, M.D., and Peter Barland, M.D., discuss

cells. It is also known for its dramatic response to steroids. The recent identification of IgG4 in the affected tissues of many chronic inflammatory syndromes has led to the recognition of a new clinicopathological entity — IgG4 RSS. Prior to the discovery of IgG4 RSS as a multiorgan disorder, many…
Authors: Peguy Saad, M.D., and Peter Barland, M.D.
Estimated Time: 1 Hour
View Course
More

Hemophagocytic Syndrome in Rheumatic Diseases

This month, Arlene Tan Tieng, M.D., Irene Blanco, M.D., and Peter Barland, M.D., discuss

abdomen and no rash, lymphadenopathy or synovitis. He was found to be pancytopenic with a WBC of 2600/mm3, an absolute neutrophil count of 1700/mm3, a hemoglobin of 8.9 gm/dL and platelets of 22,000/mm3 with schistocytes seen on the peripheral blood smear. His International Normalized Ratio (INR) was increased at…
Authors: Arlene Tan Tieng, M.D., Irene Blanco, M.D., and Peter Barland, M.D.
Estimated Time: 1 Hour
View Course
More